{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:05:14Z","timestamp":1777367114329,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1124\/dmd.110.037366","type":"journal-article","created":{"date-parts":[[2011,2,17]],"date-time":"2011-02-17T02:53:18Z","timestamp":1297911198000},"page":"763-770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Novel Cytochrome P450-Mediated Ring Opening of the 1,3,4-Oxadiazole in Setileuton, a 5-Lipoxygenase Inhibitor"],"prefix":"10.1016","volume":"39","author":[{"given":"Cheri M.","family":"Maciolek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bennett","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten","family":"Menzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastien","family":"Laliberte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Krolikowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoper R.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.110.037366_bib1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00498250600618177","article-title":"Pharmacokinetics and metabolism of UK-383,367 in rats and dogs: a rationale for long-lived plasma radioactivity","volume":"36","author":"Allan","year":"2006","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.110.037366_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/00498257109044374","article-title":"The metabolism by man of an anticonvulsant oxadiazole. An unusual metabolic route for tertiary amides","volume":"1","author":"Allen","year":"1971","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.110.037366_bib3","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/jms.1033","article-title":"Interspecies in vitro metabolism of the phosphodiesterase-4 (PDE4) inhibitor L-454,560","volume":"41","author":"Bateman","year":"2006","journal-title":"J Mass Spectrom"},{"key":"10.1124\/dmd.110.037366_bib4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1021\/tx015574b","article-title":"Biotransformation reactions of five-membered aromatic heterocyclic rings","volume":"15","author":"Dalvie","year":"2002","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.110.037366_bib5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1021\/ml100029k","article-title":"The discovery of Setileuton, a potent and selective 5-lipoxygenase inhibitor","volume":"1","author":"Ducharme","year":"2010","journal-title":"ACS Med Chem Lett"},{"key":"10.1124\/dmd.110.037366_bib6","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/anie.196603721","article-title":"The chemistry of \u03b1-carbonyl azo compounds","volume":"5","author":"Fahr","year":"1966","journal-title":"Angew Chem Int Edit"},{"key":"10.1124\/dmd.110.037366_bib7","first-page":"25","article-title":"Leukotrienes: their formation and role as inflammatory mediators","volume":"44","author":"Ford-Hutchinson","year":"1985","journal-title":"Fed Proc"},{"key":"10.1124\/dmd.110.037366_bib8","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nrd1796","article-title":"Leukotriene modifiers as potential therapeutics for cardiovascular disease","volume":"4","author":"Funk","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/dmd.110.037366_bib9","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1016\/j.bmcl.2007.06.014","article-title":"Identification and optimization of novel 1,3,4-oxadiazole EP1 receptor antagonists","volume":"17","author":"Hall","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/dmd.110.037366_bib10","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/01.ATV.0000140063.06341.09","article-title":"Leukotriene B4 strongly increases monocyte chemoattractant protein-1 in human monocytes","volume":"24","author":"Huang","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/dmd.110.037366_bib11","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1124\/dmd.104.001313","article-title":"Evidence of significant contribution from CYP3A5 to hepatic drug metabolism","volume":"32","author":"Huang","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.037366_bib12","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s002040050608","article-title":"Constitutive and induced expression by pyridine and \u03b2-naphthoflavone of rat CYP1A is sexually dimorphic","volume":"73","author":"Iba","year":"1999","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.110.037366_bib13","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJM199012203232505","article-title":"The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air","volume":"323","author":"Israel","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1124\/dmd.110.037366_bib14","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1124\/dmd.108.022624","article-title":"Metabolism of 5-isopropyl-6-(5-methyl-1,3,4-oxadiazol-2-yl)-N-(2-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)pyrrolo[2,1-f][1,2,4]triazin-4-amine (BMS-645737): identification of an unusual N-acetylglucosamine conjugate in the cynomolgus monkey","volume":"36","author":"Johnson","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.037366_bib15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0378-4274(92)90245-F","article-title":"Sex-specific cytochrome P450 as a cause of sex- and species-related differences in drug toxicity","volume":"64\/65","author":"Kato","year":"1992","journal-title":"Toxicol Lett"},{"key":"10.1124\/dmd.110.037366_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/00498257309151504","article-title":"Metabolic studies with trans-5-amino-3-[2-(5-nitro-2-furyl)vinyl]-1,2,4-[5-14C]oxadiazole (SQ 18,506): 1. Reductive cleavage of the 1,2,4-oxadizole ring","volume":"3","author":"Lan","year":"1973","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.110.037366_bib17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0272-0590(88)90157-1","article-title":"Species differences in the hydrolysis of meperidine and its inhibition by organophosphate compounds","volume":"11","author":"Luttrell","year":"1988","journal-title":"Fundam Appl Toxicol"},{"key":"10.1124\/dmd.110.037366_bib18","series-title":"Biochemistry: The Chemical Reactions of Living Cells","first-page":"464","article-title":"Coenzymes\u2014nature's special reagents","author":"Metzler","year":"1977"},{"key":"10.1124\/dmd.110.037366_bib19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bbrc.2005.08.013","article-title":"Regulation of 5-lipoxygenase enzyme activity","volume":"338","author":"R\u00e5dmark","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.110.037366_bib20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0003-9861(92)90377-9","article-title":"Cloning and characterization of a novel CYP3A1 allelic variant: analysis of CYP3A1 and CYP3A2 sex-hormone-dependent expression reveals that the CYP3A2 gene is regulated by testosterone","volume":"293","author":"Ribeiro","year":"1992","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.110.037366_bib21","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/(SICI)1097-0029(19971201)39:5<424::AID-JEMT5>3.0.CO;2-G","article-title":"Expression and inducibility of P450 enzymes during liver ontogeny","volume":"39","author":"Rich","year":"1997","journal-title":"Microsc Res Tech"},{"key":"10.1124\/dmd.110.037366_bib22","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1046\/j.1432-1033.2003.03413.x","article-title":"Two CCAAT\/enhancer binding protein sites in the cytochrome P4503A1 locus","volume":"270","author":"Rodrigues","year":"2003","journal-title":"Eur J Biochem"},{"key":"10.1124\/dmd.110.037366_bib23","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1021\/jm00166a008","article-title":"Novel quinuclidine-based ligands for the muscarinic cholinergic receptor","volume":"33","author":"Saunders","year":"1990","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.110.037366_bib24","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1124\/dmd.31.9.1161","article-title":"Substrate specificity and kinetic properties of seven heterologously expressed dog cytochromes P450","volume":"31","author":"Shou","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.037366_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0090-9556(25)06520-1","article-title":"Biotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes: role of cytochrome P4502C and 3A subfamily members","volume":"23","author":"Stearns","year":"1995","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.110.037366_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3987\/COM-02-9630","article-title":"Chlorination and subsequent cyclization to 1,3,4-oxadiazoles of N1-acyl-N3-cyanoguanidines and related compounds","volume":"60","author":"Suyama","year":"2003","journal-title":"Heterocycles"},{"key":"10.1124\/dmd.110.037366_bib27","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0090-9556(25)08216-9","article-title":"Novel cleavage of the 1,2,4-oxadiazole ring in rat metabolism of SM-6586, a dihydropyridine calcium antagonist","volume":"21","author":"Yabuki","year":"1993","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624057507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624057507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.110.037366","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T18:41:03Z","timestamp":1739904063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624057507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0090955624057507"],"URL":"https:\/\/doi.org\/10.1124\/dmd.110.037366","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Cytochrome P450-Mediated Ring Opening of the 1,3,4-Oxadiazole in Setileuton, a 5-Lipoxygenase Inhibitor","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.110.037366","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}